Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1990
Receptors for interleukin 4, interleukin 5 and interleukin 6
J Banchereau, J P Galizzi
Biochemical and Biophysical Research Communications
|
October 15, 1985
Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes
J P Galizzi, M Fosset, M Lazdunski
European Journal of Biochemistry
|
October 15, 1984
Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates
J P Galizzi, M Fosset, M Lazdunski
Biochemical and Biophysical Research Communications
|
January 13, 1984
[3H] verapamil binding sites in skeletal muscle transverse tubule membranes
J P Galizzi, M Fosset, M Lazdunski
Biochemistry
|
January 13, 1987
Monoclonal antibodies that coimmunoprecipitate the 1,4-dihydropyridine and phenylalkylamine receptors and reveal the Ca2+ channel structure
S Vandaele, M Fosset, J P Galizzi, et al.
European Journal of Pharmacology
|
September 11, 1987
Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade
J Qar, J P Galizzi, M Fosset, et al.
European Journal of Immunology
|
June 1, 1991
A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes
P Garrone, O Djossou, J P Galizzi, et al.
The Journal of Biological Chemistry
|
January 25, 1986
Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes
J P Galizzi, M Borsotto, J Barhanin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay K8644) and inhibitor (PN 200-110)
C Cognard, G Romey, J P Galizzi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1986
Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors
J P Galizzi, M Fosset, G Romey, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1990
Receptors for interleukin 4, interleukin 5 and interleukin 6
J Banchereau, J P Galizzi
Biochemical and Biophysical Research Communications
|
October 15, 1985
Characterization of the Ca2+ coordination site regulating binding of Ca2+ channel inhibitors d-cis-diltiazem, (+/-)bepridil and (-)desmethoxyverapamil to their receptor site in skeletal muscle transverse tubule membranes
J P Galizzi, M Fosset, M Lazdunski
European Journal of Biochemistry
|
October 15, 1984
Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates
J P Galizzi, M Fosset, M Lazdunski
Biochemical and Biophysical Research Communications
|
January 13, 1984
[3H] verapamil binding sites in skeletal muscle transverse tubule membranes
J P Galizzi, M Fosset, M Lazdunski
Biochemistry
|
January 13, 1987
Monoclonal antibodies that coimmunoprecipitate the 1,4-dihydropyridine and phenylalkylamine receptors and reveal the Ca2+ channel structure
S Vandaele, M Fosset, J P Galizzi, et al.
European Journal of Pharmacology
|
September 11, 1987
Receptors for diphenylbutylpiperidine neuroleptics in brain, cardiac, and smooth muscle membranes. Relationship with receptors for 1,4-dihydropyridines and phenylalkylamines and with Ca2+ channel blockade
J Qar, J P Galizzi, M Fosset, et al.
European Journal of Immunology
|
June 1, 1991
A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes
P Garrone, O Djossou, J P Galizzi, et al.
The Journal of Biological Chemistry
|
January 25, 1986
Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes
J P Galizzi, M Borsotto, J Barhanin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1986
Dihydropyridine-sensitive Ca2+ channels in mammalian skeletal muscle cells in culture: electrophysiological properties and interactions with Ca2+ channel activator (Bay K8644) and inhibitor (PN 200-110)
C Cognard, G Romey, J P Galizzi, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1986
Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors
J P Galizzi, M Fosset, G Romey, et al.
Page
of 6